Exploring a new chapter in traditional Chinese medicine: The potential of Calculus bovis in liver cancer treatment
- PMID: 39720650
- PMCID: PMC11514369
- DOI: 10.5306/wjco.v15.i12.1520
Exploring a new chapter in traditional Chinese medicine: The potential of Calculus bovis in liver cancer treatment
Abstract
In the ongoing quest for new treatments in medicine, traditional Chinese medicine offers unique insights and potential. Recently, studies on the ability of Calculus bovis to inhibit M2-type tumour-associated macrophage polarisation by modulating the Wnt/β-catenin signalling pathway to suppress liver cancer have undoubtedly revealed new benefits and hope for this field of research. The purpose of this article is to comment on this study and explore its strengths and weaknesses, thereby providing ideas for the future treatment of liver cancer.
Keywords: Calculus bovis; Liver cancer; M2 tumor-associated macrophage polarization; The tumor microenvironment; Wnt/β-catenin pathway.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Figures

Similar articles
-
Calculus bovis inhibits M2 tumor-associated macrophage polarization via Wnt/β-catenin pathway modulation to suppress liver cancer.World J Gastroenterol. 2024 Aug 7;30(29):3511-3533. doi: 10.3748/wjg.v30.i29.3511. World J Gastroenterol. 2024. PMID: 39156500 Free PMC article.
-
Reevaluating Calculus bovis: Modulating the liver cancer immune microenvironment via the Wnt/β-catenin pathway.World J Gastroenterol. 2025 Feb 14;31(6):99750. doi: 10.3748/wjg.v31.i6.99750. World J Gastroenterol. 2025. PMID: 39958448 Free PMC article.
-
Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes.World J Gastroenterol. 2024 Dec 28;30(48):5221-5224. doi: 10.3748/wjg.v30.i48.5221. World J Gastroenterol. 2024. PMID: 39735274 Free PMC article.
-
Macrophage Polarisation in the Tumour Microenvironment: Recent Research Advances and Therapeutic Potential of Different Macrophage Reprogramming.Cancer Control. 2025 Jan-Dec;32:10732748251316604. doi: 10.1177/10732748251316604. Cancer Control. 2025. PMID: 39849988 Free PMC article. Review.
-
Wnt/β-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicine.Expert Rev Mol Med. 2023 Jun 19;25:e21. doi: 10.1017/erm.2023.16. Expert Rev Mol Med. 2023. PMID: 37332167 Review.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. - PubMed
-
- Shi JF, Cao M, Wang Y, Bai FZ, Lei L, Peng J, Feletto E, Canfell K, Qu C, Chen W. Is it possible to halve the incidence of liver cancer in China by 2050? Int J Cancer. 2021;148:1051–1065. - PubMed
-
- Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4:16. - PubMed
LinkOut - more resources
Full Text Sources